NICaS, the non-invasive hemodynamic & fluid measuring system, provides each patient with a personal hemodynamic profile – information otherwise available only in high-level hospital care.
With this information, healthcare providers are able to treat their patients better, resulting in a substantial reduction in readmission rates, thus lowering the economic, as well as clinical, burden of Heart Failure.
Our Technology was developed to improve medical outcomes, both in chronic and acute conditions, and in various clinical applications including: heart failure, hypertension, preeclampsia management, hemodialysis and dialysis, CRT optimization, hemodynamic monitoring during anesthesia and infectious disease hemodynamic management.
The technology is FDA approved, CE marked and cleared for marketing in many countries worldwide for monitoring hemodynamic parameters, including stroke volume, stroke index, heart rate, cardiac index, cardiac output, and total peripheral resistance. In addition, it has a patent for its GGI parameter, an innovative assessment tool that is able to detect the smallest decrease of the left ventricular function.